NCT03907423View on ClinicalTrials.gov

Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

January 19, 2021

Study Completion Date

January 31, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosuvastatin10 mg tablet

Diabetic patients treated with Rosuvastatin 10mg/day plus Glimepiride 1-8mg/day and Metformin 500-2550 mg/day oral

DRUG

Placebo Oral Tablet

Diabetic patients treated with Glimepiride 1-8mg/day and Metformin 500-2550 mg/day oral

Trial Locations (1)

31527

Damanhour Medical National Institute, Damanhūr

All Listed Sponsors
lead

Rehab Werida

OTHER

NCT03907423 - Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin | Biotech Hunter | Biotech Hunter